• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Quantification of gold nanoparticle accumulation in tissue by two-photon luminescence microscopy

6 de June de 2019
Nanoscale. 2019 Jun 13;11(23):11331-11339. doi: 10.1039/c9nr01198f.ABSTRACTNanomedicine…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-06-06 10:00:002019-06-06 10:00:00Quantification of gold nanoparticle accumulation in tissue by two-photon luminescence microscopy

Non-invasive and quantitative in vivo monitoring of gold nanoparticle concentration and tissue hemodynamics by hybrid optical spectroscopies

13 de March de 2019
Nanoscale. 2019 Mar 21;11(12):5595-5606. doi: 10.1039/c8nr08790c.ABSTRACTOwing…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-03-13 10:00:002019-03-13 10:00:00Non-invasive and quantitative in vivo monitoring of gold nanoparticle concentration and tissue hemodynamics by hybrid optical spectroscopies

Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies

20 de November de 2018
Br J Haematol. 2019 May;185(3):608-612. doi: 10.1111/bjh.15583.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-11-20 11:00:002018-11-20 11:00:00Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies

Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility

18 de November de 2018
Nat Commun. 2018 Nov 16;9(1):4826. doi: 10.1038/s41467-018-07172-3.ABSTRACTAngiogenesis…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-11-18 11:00:002018-11-18 11:00:00Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility

Unraveling the Role of Angiogenesis in Cancer Ecosystems

18 de July de 2018
Front Oncol. 2018 Jul 2;8:248. doi: 10.3389/fonc.2018.00248.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-07-18 10:00:002018-07-18 10:00:00Unraveling the Role of Angiogenesis in Cancer Ecosystems

TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

27 de June de 2018
J Clin Invest. 2018 Aug 31;128(9):3887-3905. doi: 10.1172/JCI96393.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-06-27 10:00:002018-06-27 10:00:00TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

26 de May de 2018
Oncologist. 2019 Jan;24(1):38-46. doi: 10.1634/theoncologist.2017-0622.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-05-26 10:00:002018-05-26 10:00:00Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

17 de February de 2018
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1216-1229. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-02-17 11:00:002018-02-17 11:00:00ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

18 de November de 2017
Mol Cancer Ther. 2018 Feb;17(2):532-543. doi: 10.1158/1535-7163.MCT-17-0643.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-18 11:00:002017-11-18 11:00:00A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

Angiogenesis and Metabolism: Entwined for Therapy Resistance

19 de July de 2017
Trends Cancer. 2017 Jan;3(1):10-18. doi: 10.1016/j.trecan.2016.11.007.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-07-19 10:00:002017-07-19 10:00:00Angiogenesis and Metabolism: Entwined for Therapy Resistance

Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics

1 de July de 2017
Biomed Opt Express. 2017 Apr 19;8(5):2563-2582. doi: 10.1364/BOE.8.002563.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-07-01 10:00:002017-07-01 10:00:00Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics

Sprouting strategies and dead ends in anti-angiogenic targeting of NETs

5 de May de 2017
J Mol Endocrinol. 2017 Jul;59(1):R77-R91. doi: 10.1530/JME-17-0029.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-05-05 10:00:002017-05-05 10:00:00Sprouting strategies and dead ends in anti-angiogenic targeting of NETs
Page 2 of 7‹1234›»

Filter by categories

  • Alemany’s & Piulats’s lab (134)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (111)
  • Sin categoría (12)
  • Sureda's & Farre's Lab (318)
  • Viñals's lab (113)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}